These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 7819816

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention.
    Sigle JP, Thierbach J, Infanti L, Muriset M, Hunziker G, Chassot K, Niederhauser C, Gowland P, Holbro A, Sunic K, Buser A, Fontana S.
    Vox Sang; 2013 Oct; 105(3):244-52. PubMed ID: 23773018
    [Abstract] [Full Text] [Related]

  • 6. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].
    Basire A, Picard C.
    Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A specific assay for anti-HLA antibodies: application to platelet donor selection.
    Millard FE, Tani P, McMillan R.
    Blood; 1987 Nov; 70(5):1495-9. PubMed ID: 3311206
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J, Xia W, Deng J, Xu X, Shao Y, Ding H, Chen Y, Liu J, Chen D, Ye X, Santoso S.
    Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
    [Abstract] [Full Text] [Related]

  • 13. Allergic transfusion reactions to platelets are more commonly associated with prepooled than apheresis components.
    Xiao W, Tormey CA, Capetillo A, Maitta RW.
    Vox Sang; 2013 Nov; 105(4):334-40. PubMed ID: 23802769
    [Abstract] [Full Text] [Related]

  • 14. ABO and platelet transfusion therapy.
    Cooling L.
    Immunohematology; 2007 Nov; 23(1):20-33. PubMed ID: 17425412
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Platelet alloimmunization after transfusion. A prospective study in 117 heart surgery patients.
    Taaning E, Simonsen AC, Hjelms E, Svejgaard A, Morling N.
    Vox Sang; 1997 Nov; 72(4):238-41. PubMed ID: 9228715
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy.
    De Clippel D, Baeten M, Torfs A, Emonds MP, Feys HB, Compernolle V, Vandekerckhove P.
    Transfusion; 2014 Dec; 54(12):3036-42. PubMed ID: 24863861
    [Abstract] [Full Text] [Related]

  • 20. Platelet concentrates, from whole blood or collected by apheresis?
    van der Meer PF.
    Transfus Apher Sci; 2013 Apr; 48(2):129-31. PubMed ID: 23535511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.